Dr. Lee Cohen Discusses Menopause on the It’s Not a Crisis Podcast
In this episode of It’s Not a Crisis, Dr. Lee Cohen speaks with host Doryn Wallach about the struggles many women experience during the menopausal transition. For most women, menopausal symptoms are manageable, but for a sizable subset of midlife women, these symptoms can negatively affect sleep, mood, and quality of life. While clinical guidelines suggest that menopausal symptoms typically last from 6 months to 2 years, new research suggests that [...]
Essential Reads: Emerging Evidence of the Long-Term Effects of Cannabis on the Developing Brain
Despite decreasing rates of alcohol and tobacco use during pregnancy, the use of cannabis use during pregnancy is on the rise. We are seeing an increasing number of women in our clinic who are using marijuana on a regular basis — recreationally and medically prescribed. This is no surprise given that many states have or are now moving forward with the legalization of medical marijuana. The majority of marijuana users are [...]
Prenatal Exposure to Valproic Acid Linked to Increased Risk for Autism, ADHD
Prenatal exposure to valproate has been associated with an elevated risk (10%) for a broad range of congenital malformations including neural tube defects, as well as adverse neurodevelopmental sequelae, including lower IQ and developmental delays in offspring. Several studies have shown that exposure to valproic acid (Depakote) may be associated with increased risk of autism spectrum disorders or autistic traits and/or attentional problems. A new study examines the association between prenatal [...]
Weekly Roundup for FEBRUARY 5, 2021: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health, covering topics related to premenstrual symptoms, perinatal mood and anxiety disorders, use of medications in pregnant and breastfeeding women, perinatal substance use, and menopausal mental health. For more detailed descriptions of many of these topics, you can sign up to receive our weekly CWMH NEWSLETTER which comes out every Thursday.  Ruta Nonacs, MD PhD PMS AND PMDD [...]
Recruiting New Mothers with Postpartum Depression for the Skylark Study
In 2019, brexanolone was introduced by Sage Therapeutics as Zulresso, a novel treatment for postpartum depression. The oral version of this novel antidepressant – SAGE 217 or zuranolone – is now finishing up its Phase 3 trials. Like brexanolone, SAGE-217 is a neurosteroid, an analogue of allopregnanolone which is a positive allosteric modulator of the GABA-A receptor. What distinguishes SAGE-217 from brexanolone is that it has much better oral bioavailability and [...]
Essential Reads:Â Clinical Challenges in the Treatment of Perimenopausal Women with Schizophrenia
Women with schizophrenia may experience worsening of their symptoms as they transition into the menopause.Â